Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis

Bibliographic Details
Main Authors:	Yokota Shumpei, Imagawa Tomoyuki, Kizawa Toshitaka, Kikuchi Masako, Nozawa Tomo, Miyamae Takako
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
by: Mori Masaaki, et al.
Published: (2011-09-01)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
by: Kaori Hisa, et al.
Published: (2017-01-01)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
by: Yokota S, et al.
Published: (2008-09-01)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
by: Murakami M, et al.
Published: (2012-07-01)

THE CLINICAL AND PARACLINICAL EFFICACY OF TOCILIZUMAB IN JUVENILE IDIOPATHIC ARTHRITIS
by: Ninel REVENCO, et al.
Published: (2021-06-01)

Rapid desensitisation to tocilizumab in systemic idiopathic juvenile arthritis
by: Rosalaura Villarreal González, et al.
Published: (2021-03-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
by: Inayama Yoshiaki, et al.
Published: (2010-02-01)

TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2011-05-01)

THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
by: M. I. Kaleda, et al.
Published: (2018-01-01)

Psoriasiform Dermatitis Developing during Treatment of Juvenile Idiopathic Arthritis with Tocilizumab
by: Yoshiaki Matsushima, et al.
Published: (2019-11-01)

TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2011-01-01)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
by: Hofer M, et al.
Published: (2011-09-01)

The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
by: Srdjan Pasic, et al.
Published: (2011-09-01)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
by: Sleptsova T, et al.
Published: (2011-09-01)

Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis
by: M. M. Kostik, et al.
Published: (2013-09-01)

EXPERIENCE IN APPLICATION OF TOCILIZUMAB AT SYSTEM VARIANT OF JUVENILE IDIOPATHIC ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. А. Malievskii, et al.
Published: (2014-05-01)

Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis
by: Y. M. Spivakovskiy, et al.
Published: (2016-02-01)

CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Tocilizumab in refractory juvenile idiopathic arthritis with associated uveitis: a case report
by: Filipe Sousa-Neves, et al.
Published: (2019-04-01)

Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis – single-centre experience
by: Justyna Roszkiewicz, et al.
Published: (2018-10-01)

Posterior reversible encephalopathy syndrome during treatment with tocilizumab in juvenile idiopathic arthritis
by: Marcos Rosa Júnior, et al.

EXPERIENCE OF USING DRUG TOCILIZUMAB IN A BOY WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2013-11-01)

CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: O. L. Lomakina, et al.
Published: (2014-01-01)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019-04-01)

A HISTORY CASE OF TOCILIZUMAB USAGE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2012-07-01)

Experience in the use of tocilizumab in patient with systemic juvenile idiopathic arthritis and type 1 diabetes
by: E. A. Ligostaeva, et al.
Published: (2016-06-01)

Tocilizumab in the Treatment of Juvenile Rheumatoid Arthritis
by: V.V. Berejniy, et al.
Published: (2015-03-01)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
by: Yamaguchi Ken-ichi, et al.
Published: (2012-07-01)

The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study
by: Mikhail M. Kostik, et al.
Published: (2017-06-01)

Tocilizumab in management of refractory juvenile idiopathic arthritis, 10 years of experience at tertiary university hospital
by: Mohammed A. Muzaffer, et al.
Published: (2021-07-01)

Analysis of gender differences in genetic risk: association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population.
by: Keisuke Kadota, et al.
Published: (2013-01-01)

Cost–utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand
by: Nitichen Kittiratchakool, et al.
Published: (2020-09-01)

CLINICAL CASE OF USING TOCILIZUMAB FOR A FEMALE PATIENT WITH AN EARLY DEBUT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: О. L. Lomakina, et al.
Published: (2014-10-01)

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
by: Masaki Shimizu, et al.
Published: (2020-01-01)

Case reports Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab
by: Małgorzata Kwiatkowska, et al.
Published: (2015-08-01)

Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis
by: A. V. Krasnopol’skaja, et al.
Published: (2015-11-01)

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody
by: Takako Miyamae, et al.
Published: (2018-01-01)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
by: Espada G, et al.
Published: (2011-09-01)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
by: V. A. Kel'tsev, et al.
Published: (2015-04-01)